Blindness News and Research

RSS

Penn researchers show that canine X-linked retinitis pigmentosa can be cured over the long term

Three years ago, a team from the University of Pennsylvania announced that they had cured X-linked retinitis pigmentosa, a blinding retinal disease, in dogs. Now they've shown that they can cure the canine disease over the long term, even when the treatment is given after half or more of the affected photoreceptor cells have been destroyed.

13 Oct 2015

Tresiba and Ryzodeg approved to improve blood sugar control in adults with diabetes mellitus

The U.S. Food and Drug Administration today approved Tresiba (insulin degludec injection) and Ryzodeg 70/30 (insulin degludec/insulin aspart injection) to improve blood sugar (glucose) control in adults with diabetes mellitus.

9 Oct 2015

Bankers Healthcare Group's company-wide diabetes awareness campaign to run through November

Bankers Healthcare Group, the leading provider of financial solutions for healthcare professionals, recently launched a company-wide diabetes awareness campaign that will run through November.

8 Oct 2015

Up to 1 billion people could be at risk of going blind by 2050, say researchers

Up to 1 billion people could be at risk of blindness by the middle of the century if an emerging short-sightedness (myopia) epidemic is ignored say researchers at the Brien Holden Vision Institute.

8 Oct 2015

Envisia's ENV515 (travoprost XR) meets primary efficacy endpoint in phase 2a glaucoma trial

Envisia Therapeutics, a clinical-stage biotechnology company focused on the development of novel extended-release therapies in ophthalmology, today reported results from its first clinical trial of the Company's lead product candidate, ENV515 (travoprost XR).

6 Oct 2015

NIH-funded researchers test new gene therapy to improve visual function in mice

Researchers funded by the National Institutes of Health have developed a novel mouse model for the vision disorder Leber hereditary optic neuropathy (LHON), and found that they can use gene therapy to improve visual function in the mice. LHON is one of many diseases tied to gene mutations that damage the tiny energy factories that power our cells, called mitochondria.

6 Oct 2015

Allergan receives FDA approval to market JUVEDERM ULTRA XC for use in lips

Allergan plc, a leading global pharmaceutical company, today announced that the company has received approval from the U.S. Food and Drug Administration to market JUVEDERM ULTRA XC for injection into the lips and perioral area for lip augmentation in adults over the age of 21. JUVEDERM ULTRA XC instantly adds fullness to the lips and is the only dermal filler that has proven results lasting up to one year for lip augmentation.

1 Oct 2015

New research sheds light on how retina sets its own biological rhythm using neuropsin

Researchers at Johns Hopkins and the University of Washington report new research that sheds light on how the retina sets its own biological rhythm using a novel light-sensitive pigment, called neuropsin, found in nerve cells at the back of the eye.

1 Oct 2015

Researchers receive NIH grants to find genomic regions containing variants that affect disease risk

Six new grants from the National Institutes of Health will support researchers to develop new computational approaches for searching among millions of genomic variants to find those that make a difference in disease susceptibility or in other traits.

23 Sep 2015

University of Alberta researchers discover diabetes 'dimmer' switch

Patrick MacDonald has dedicated much of his life to diabetes research. It's a job he knows is far too large and complex for any one person, but with his latest publication, he knows his work is playing a part.

23 Sep 2015

Quethera receives seed investment funding to develop gene therapy for glaucoma

Quethera, a gene therapy company developing a treatment for glaucoma that could prevent blindness, has received seed investment funding led by Midven’s Rainbow Seed Fund alongside co-investor Cambridge Enterprise, the commercialisation arm of the University of Cambridge, to continue pre-clinical development of their therapy.

18 Sep 2015

UK’s GPs, optometrists confirm link between smoking and loss of vision

Smokey eyes are regarded as sexy, sultry and stunning. But nothing could be further from the truth, according to new research unveiled this National Eye Health Week.

18 Sep 2015

Amgen, Xencor partner to develop and commercialize new therapeutics for cancer immunotherapy, inflammation

Amgen and Xencor, Inc. announced today that the two companies have entered into a research and license agreement to develop and commercialize novel therapeutics in the areas of cancer immunotherapy and inflammation.

16 Sep 2015

World Scientific's latest book to be launched on Stem Cell Awareness Day

While the world knows the $3 billion California Institute for Regenerative Medicine sprang from the citizen's initiative, Proposition 71, few people know the struggle required, nor what happened after California said "Yes!"

16 Sep 2015

AMD Alliance hosts webinar to promote awareness and knowledge about macular disease

14 – 20 September marks global AMD Awareness Week 2015. Age related macular degeneration (AMD) is a progressive eye disease which is the leading cause of blindness in over 50s globally.

16 Sep 2015

FDA grants Orphan Drug Designation to TxCell's Col-Treg for treatment of autoimmune uveitis

TxCell SA, a biotechnology company developing innovative, personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that the U.S. Food and Drug Administration's Office of Orphan Products Development has granted Orphan Drug Designation (ODD) to TxCell's Col-Treg, a personalized T cell immunotherapy using collagen-II specific regulatory T-cells, for the treatment of chronic non-infectious uveitis.

15 Sep 2015

Scientists elucidate genetic interaction that may prove key to development, progression of glaucoma

Scientists at the University of California, San Diego School of Medicine have elucidated a genetic interaction that may prove key to the development and progression of glaucoma, a blinding neurodegenerative disease that affects tens of millions of people worldwide and is a leading cause of irreversible blindness.

11 Sep 2015

Envision inaugurates 10th Annual Conference, honors outstanding achievements in low vision rehabilitation

Envision, the Wichita, Kan.-based not-for-profit organization that supports those who are blind and visually impaired, officially opened its 10th Annual Conference at The Grand Hyatt in downtown Denver this morning with a session honoring outstanding commitment to improving the quality of life of those who are blind and visually impaired and keynote addresses from two individuals representing the great athletic accomplishments those with vision loss can achieve.

11 Sep 2015

IRIDEX launches novel intra-ocular pressure monitoring device

IRIDEX Corporation today announced that it has added a novel intra-ocular pressure (IOP) monitoring device called a tonometer to its suite of commercial products for the global glaucoma market. The new device comes to IRIDEX through a distribution agreement with Icare Finland Plc, a subsidiary of the Revenio Group Corporation, the creator of the tonometer.

8 Sep 2015

Kilimanjaro Project receives 2015 António Champalimaud Vision Award

The 2015 António Champalimaud Vision Award is given to three institutions that have developed a unique collaborative project to achieve the common goal of fighting blindness and poverty in Africa.

7 Sep 2015

Blindness News and Research

Penn researchers show that canine X-linked retinitis pigmentosa can be cured over the long term

Tresiba and Ryzodeg approved to improve blood sugar control in adults with diabetes mellitus

Bankers Healthcare Group's company-wide diabetes awareness campaign to run through November

Up to 1 billion people could be at risk of going blind by 2050, say researchers

Envisia's ENV515 (travoprost XR) meets primary efficacy endpoint in phase 2a glaucoma trial

NIH-funded researchers test new gene therapy to improve visual function in mice

Allergan receives FDA approval to market JUVEDERM ULTRA XC for use in lips

New research sheds light on how retina sets its own biological rhythm using neuropsin

Researchers receive NIH grants to find genomic regions containing variants that affect disease risk

University of Alberta researchers discover diabetes 'dimmer' switch

Quethera receives seed investment funding to develop gene therapy for glaucoma

UK’s GPs, optometrists confirm link between smoking and loss of vision

Amgen, Xencor partner to develop and commercialize new therapeutics for cancer immunotherapy, inflammation

World Scientific's latest book to be launched on Stem Cell Awareness Day

AMD Alliance hosts webinar to promote awareness and knowledge about macular disease

FDA grants Orphan Drug Designation to TxCell's Col-Treg for treatment of autoimmune uveitis

Scientists elucidate genetic interaction that may prove key to development, progression of glaucoma

Envision inaugurates 10th Annual Conference, honors outstanding achievements in low vision rehabilitation

IRIDEX launches novel intra-ocular pressure monitoring device

Kilimanjaro Project receives 2015 António Champalimaud Vision Award

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News